Blue Trust Inc
COGT icon

Blue Trust Inc’s Cogent Biosciences COGT Stock Holding History

Blue Trust Inc’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-133
Closed -$5.15K – 2576
2026
Q2 		$5.15K Buy
+133
New +$4.65K ﹤0.01% 2018
2023
Q1 		– Sell
-117
Closed -$2K – 2348
2022
Q4 		$2K Buy
117
+40
+52% +$496 ﹤0.01% 1908
2022
Q3 		$1K Buy
77
+22
+40% +$302 ﹤0.01% 1898
2022
Q2 		$0 Buy
+55
New +$375 ﹤0.01% 1904

Other funds holding COGT

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Harbor Investment Advisory
Harbor Investment Advisory Lutherville, Maryland $1.47B AUM 24.2% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Blue Trust Inc's COGT Position: Q3 2026 in Review

Blue Trust Inc sold out of Cogent Biosciences (COGT) in Q3 2026, closing a stake of 133 shares — an estimated $5.15K sold.

Blue Trust Inc first reported a position in COGT in Q2 2022 and held it in 4 quarters. The position peaked at $5.15K in Q2 2026. 29 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

  • Blue Trust Inc reported no remaining Cogent Biosciences position as of Q3 2026 after selling out during the quarter.
  • Blue Trust Inc sold 133 Cogent Biosciences shares in Q3 2026, an estimated $5.15K.
  • Blue Trust Inc first reported a position in Cogent Biosciences in Q2 2022 and held it in 4 quarters.
  • Blue Trust Inc's Cogent Biosciences position peaked at $5.15K in Q2 2026.
  • 29 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on Blue Trust Inc's 13F filing for Q3 2026, filed 15 Oct 2026.